Oxford Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-53,449
| Closed | -$230K | – | 1668 |
|
|
2019
Q1 | $230K | Buy |
53,449
+6,557
| +14% | +$28.2K | 0.01% | 1474 |
|
|
2018
Q4 | $270K | Buy |
+46,892
| New | +$270K | 0.01% | 1436 |
|
|
2018
Q2 | – | Sell |
-50,337
| Closed | -$565K | – | 1666 |
|
|
2018
Q1 | $565K | Sell |
50,337
-50,795
| -50% | -$570K | 0.01% | 1190 |
|
|
2017
Q4 | $686K | Buy |
101,132
+55,894
| +124% | +$379K | 0.01% | 1083 |
|
|
2017
Q3 | $369K | Buy |
45,238
+10,471
| +30% | +$85.4K | 0.01% | 1293 |
|
|
2017
Q2 | $156K | Buy |
+34,767
| New | +$156K | ﹤0.01% | 1387 |
|